Drug Discovery companies

Achira develops atomistic foundation simulation models combining machine learning and physics-based methods to advance drug discovery.

Absentia Labs builds AI foundation models from biological and clinical data to predict drug behavior and accelerate pharmaceutical development.

Matterworks, Inc. builds AI-powered tools for extracting insights from biological data to support therapeutic discovery, drug development, and biomanufacturing.

Sobek AI builds AI-driven infrastructure for co-innovation networks in life sciences.

Iambic Therapeutics develops AI-driven platforms to accelerate the discovery of novel medicines for serious diseases.

N-Power Medicine develops an AI-powered clinical research system for community oncology to increase trial participation and speed up drug development.

PANTHERx Rare is the largest independent US rare disease pharmacy, operating a technology-driven care model licensed across all 50 states.